Institutional experience and pooled survival analysis of chemotherapy based multimodal management in poorly differentiated chordoma

Jingyu Xing, Hao Zhang, Zijie Yuan, Xinghao Cao, Tao Tan, Jinbo Hu, Wenlan Zhi, Chenglong Zhao, Cheng Yang · 2026

Read Institutional experience and pooled survival analysis of chemotherapy based multimodal management in poorly differentiated chordoma by Jingyu Xing, Hao Zhang, Zijie Yuan, Xinghao Cao, Tao Tan, Jinbo Hu, Wenlan Zhi, Chenglong Zhao, Cheng Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13369278.txt.

Description

Jingyu Xing and co-authors share their center's experience treating a rare, poorly differentiated bone tumor called chordoma, in a 2026 paper. The tumor is aggressive and returns early. Evidence on how chemotherapy fits into care is limited, so the team combine their cases with a pooled review.

Five patients with spinal tumors were treated from 2021 to 2025 with surgery plus a two-drug chemotherapy regimen. Response before surgery and survival were assessed. The authors also review published cases with treatment and outcome data, comparing survival by chemotherapy exposure and other factors. Their series patients were young on average, with a mean age near twenty-one.

Catalog record

CREATORJingyu Xing, Hao Zhang, Zijie Yuan, Xinghao Cao, Tao Tan, Jinbo Hu, Wenlan Zhi, Chenglong Zhao, Cheng Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13369278

Browse the full library · About the Tower of Babel